Abstract
Owen K. Challen, Evelyn Fitzsimons, Wyatt W. Anderson, Daniella Liao, Willie Wu, Vanessa G. P. Souza, Katya Benard, Julia R. Naso, Spencer D. Martin, Wan Ling Lam, Katey S.S. Enfield
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
10.1038/s41392-024-01947-5 · 2024
Relationship between tertiary lymphoid structure and the prognosis and clinicopathologic characteristics in solid tumors
10.7150/ijms.56347 · 2021
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy
10.3389/fimmu.2024.1413067 · 2024
Tertiary lymphoid structures in cancer: maturation and induction
10.3389/fimmu.2024.1369626 · 2024
Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities
10.1186/s13045-025-01754-7 · 2025
Cancer-associated fibroblasts in the single-cell era
10.1038/s43018-022-00411-z · 2022
Diversity and biology of cancer-associated fibroblasts
10.1152/physrev.00048.2019 · 2021
A framework for advancing our understanding of cancer-associated fibroblasts
10.1038/s41568-019-0238-1 · 2020
Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts
10.1016/j.celrep.2021.109422 · 2021
Fibroblastic reticular cells at the nexus of innate and adaptive immune responses
10.1111/imr.12748 · 2019
A local subset of mesenchymal cells expressing the transcription factor Osr1 orchestrates lymph node initiation
10.1016/j.immuni.2023.04.014 · 2023
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
10.1002/mco2.489 · 2024
Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer
10.1016/j.cell.2024.10.042 · 2025
Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer
10.1016/j.ccell.2026.03.004 · 2026
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma
10.1038/s41467-024-52153-4 · 2024
Association of CCL21+ CAFs with B-cell recruitment and TLS maturation in penile squamous cell carcinoma
10.1007/s00262-026-04348-5 · 2026
Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications
10.1186/s12943-025-02533-1 · 2025
Spatiotemporal mapping of tertiary lymphoid structure heterogeneity shapes immune niches and clinical outcomes in intrahepatic cholangiocarcinoma
10.64898/2026.01.02.697439 · 2026
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
10.1016/j.ccell.2022.04.011 · 2022
Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches
10.1016/j.ccell.2025.09.001 · 2025
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts
10.1084/jem.20210815 · 2022
Exploring the diversity of cancer-associated fibroblasts: insights into mechanisms of drug resistance
10.3389/fcell.2024.1403122 · 2024
Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts
10.1158/2159-8290.cd-19-0094 · 2019
Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets
10.1186/s43556-024-00233-8 · 2024
The tumor microenvironment is an ecosystem sustained by metabolic interactions
10.1016/j.celrep.2025.115432 · 2025
Regulation, maintenance, and remodeling of high endothelial venules in homeostasis, inflammation, and cancer
10.1016/j.cophys.2023.100705 · 2023
High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapy
10.1186/s12885-025-15529-3 · 2026
Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy
10.1016/j.ccell.2022.01.002 · 2022
Tertiary lymphoid structures in anticancer immunity
10.1038/s41568-024-00728-0 · 2024
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
10.1016/j.ccell.2022.11.002 · 2022
Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer
10.1038/s41467-025-65421-8 · 2025
Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer
10.1158/0008-5472.can-11-0431 · 2011
Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function
10.1016/j.immuni.2005.10.002 · 2005
Lymphotoxin in physiology of lymphoid tissues - implication for antiviral defense
10.1016/j.cyto.2016.08.018 · 2018
High endothelial venules: a vascular perspective on tertiary lymphoid structures in cancer
10.3389/fimmu.2021.736670 · 2021
Role of the lymphotoxin/LIGHT system in the development and maintenance of reticular networks and vasculature in lymphoid tissues
10.3389/fimmu.2014.00047 · 2014
VEGFD/VEGFR2 axis induces the dedifferentiation of high endothelial venules and impairs lymphocyte homing
10.1172/jci.insight.191041 · 2025
Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma
10.1016/j.xcrm.2025.102200 · 2025
Single-cell spatial analysis identifies ID1-high endothelial cells in tertiary lymphoid structures as predictors of durable response to immunotherapy in non-small cell lung cancer
10.1186/s12935-025-04161-7 · 2026
Interstitial dendritic cell guidance by haptotactic chemokine gradients
10.1126/science.1228456 · 2013
GABA promotes resistance to immunotherapy in patients with TLS-positive tumors
10.1016/j.ccell.2026.06.006 · doi-reference
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application
10.1186/s12943-024-01980-6 · doi-reference
Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts
10.1038/s41467-025-56462-0 · doi-reference
Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma
10.1016/j.ccr.2012.01.007 · doi-reference
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
10.1038/nm.4123 · doi-reference
Matrix crosslinking forces tumor progression by enhancing integrin signaling
10.1016/j.cell.2009.10.027 · doi-reference
Molecular remodeling of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 immunotherapy
10.3389/fonc.2026.1754311 · doi-reference
Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade
10.1158/0008-5472.can-21-4141 · doi-reference
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer
10.1073/pnas.1320318110 · doi-reference
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
10.1038/nature25501 · doi-reference
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer
10.1016/j.immuni.2022.02.001 · doi-reference
Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma
10.1016/j.ccr.2014.04.021 · doi-reference
Atezolizumab for first-line treatment of metastatic nonsquamous NSCLC
10.1056/nejmoa1716948 · doi-reference
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
10.1056/nejmoa1816714 · doi-reference
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
10.1126/scitranslmed.aak9679 · doi-reference
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
10.1126/scitranslmed.aak9670 · doi-reference
Normalizing tumor microenvironment to treat cancer: Bench to bedside to biomarkers
10.1200/jco.2012.46.3653 · doi-reference
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
10.1126/science.1104819 · doi-reference
Deciphering functional tumor-immune crosstalk through highly multiplexed imaging and deep visual proteomics
10.1016/j.molcel.2024.12.023 · doi-reference
PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells
10.1038/ni.1877 · doi-reference
Deep visual proteomics defines single-cell identity and heterogeneity
10.1038/s41587-022-01302-5 · doi-reference
An introduction to spatial transcriptomics for biomedical research
10.1186/s13073-022-01075-1 · doi-reference
Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples
10.1038/s41467-025-63414-1 · doi-reference
A tertiary lymphoid structures-based pathological score predicts survival and recurrence in colorectal cancer patients
10.1016/j.imbio.2025.152911 · doi-reference
Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
10.1136/jitc-2022-005531 · doi-reference
Mature tertiary lymphoid structures indicate good chemotherapy response and prognosis in advanced colorectal cancer
10.1002/ags3.70142 · doi-reference
Automated quantification of tertiary lymphoid structures in human tumor samples using immunofluorescence and AI-powered analysis pipeline
10.1007/978-1-0716-4184-2_11 · doi-reference
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions
10.1016/j.ccell.2024.09.007 · doi-reference
Comprehensive analysis of single-cell and bulk RNA sequencing data reveals an EGFR signature for predicting immunotherapy response and prognosis in pan-cancer
10.3389/fimmu.2025.1604394 · doi-reference
A tertiary lymphoid structure-related gene signature predicts prognosis and treatment response in hepatocellular carcinoma
10.14740/wjon2646 · doi-reference
Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers
10.1186/gm529 · doi-reference
Analyzing the tumor microenvironment by flow cytometry
10.1007/978-1-4939-3801-8_8 · doi-reference
Comprehensive analysis of scRNA-seq and bulk RNA-seq identified TIMP1 as a prognostic marker in colorectal cancer
10.4110/in.2025.25.e38 · doi-reference
Picturing of the lung tumor cellular composition by multispectral flow cytometry
10.3389/fimmu.2022.827719 · doi-reference
Development and validation of a machine learning model for detection and classification of tertiary lymphoid structures in gastrointestinal cancers
10.1001/jamanetworkopen.2022.52553 · doi-reference
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
10.1111/imr.12405 · doi-reference
T cell activation in rheumatoid synovium is B cell dependent
10.4049/jimmunol.167.8.4710 · doi-reference
The emerging role of tertiary lymphoid structures in breast cancer: A narrative review
10.3390/cancers16020396 · doi-reference
Heberden oration, 1964. Some immunologic aspects of the connective tissue diseases
10.1136/ard.24.2.103 · doi-reference
Organization of the invading lymphoid tissue in human lymphoid thyroiditis
10.1111/j.1365-3083.1974.tb01260.x · doi-reference